LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 186

Search options

  1. Article ; Online: Towards more efficient assessment of ulcerative colitis drugs.

    Carbonnel, Franck

    The lancet. Gastroenterology & hepatology

    2018  Volume 4, Issue 1, Page(s) 8–9

    MeSH term(s) Colitis, Ulcerative ; Drug Development ; Humans ; Mesalamine
    Chemical Substances Mesalamine (4Q81I59GXC)
    Language English
    Publishing date 2018-10-18
    Publishing country Netherlands
    Document type Journal Article ; Comment
    ISSN 2468-1253
    ISSN (online) 2468-1253
    DOI 10.1016/S2468-1253(18)30342-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Networks meet ulcerative colitis.

    Carbonnel, Franck

    The lancet. Gastroenterology & hepatology

    2018  Volume 3, Issue 11, Page(s) 730–731

    MeSH term(s) Colitis, Ulcerative ; Humans ; Network Meta-Analysis
    Language English
    Publishing date 2018-11-12
    Publishing country Netherlands
    Document type Journal Article ; Comment
    ISSN 2468-1253
    ISSN (online) 2468-1253
    DOI 10.1016/S2468-1253(18)30283-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reply.

    Meyer, Antoine / Boutron-Ruault, Marie-Christine / Carbonnel, Franck

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2023  Volume 21, Issue 9, Page(s) 2439

    Language English
    Publishing date 2023-01-05
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2022.12.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Editorial: in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation.

    Meyer, Antoine / Amiot, Aurélien / Carbonnel, Franck

    Alimentary pharmacology & therapeutics

    2023  Volume 57, Issue 9, Page(s) 1032–1033

    MeSH term(s) Humans ; Colitis, Ulcerative/epidemiology ; Colitis, Ulcerative/genetics ; Crohn Disease/epidemiology ; Crohn Disease/genetics ; Risk Factors
    Language English
    Publishing date 2023-04-12
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17432
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Editorial: subcutaneous CT-P13 in Crohn's disease and ulcerative colitis-small change, big consequences.

    Carbonnel, Franck / Meyer, Antoine

    Alimentary pharmacology & therapeutics

    2021  Volume 55, Issue 2, Page(s) 251–252

    MeSH term(s) Antibodies, Monoclonal ; Colitis, Ulcerative ; Crohn Disease/diagnostic imaging ; Humans ; Infliximab
    Chemical Substances Antibodies, Monoclonal ; CT-P13 ; Infliximab (B72HH48FLU)
    Language English
    Publishing date 2021-12-30
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.16709
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease.

    Meyer, Antoine / Miranda, Sara / Drouin, Jérôme / Weill, Alain / Carbonnel, Franck / Dray-Spira, Rosemary

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2024  

    Abstract: Background & aims: Limited data are available on the consequences of prenatal exposure to vedolizumab and ustekinumab. We aimed to compare the safety of vedolizumab and ustekinumab with that of anti-tumor necrosis factor (TNF) in pregnant women with ... ...

    Abstract Background & aims: Limited data are available on the consequences of prenatal exposure to vedolizumab and ustekinumab. We aimed to compare the safety of vedolizumab and ustekinumab with that of anti-tumor necrosis factor (TNF) in pregnant women with inflammatory bowel diseases (IBD).
    Methods: Using nationwide, comprehensive data of the EPI-MERES registry, we identified pregnancies in women with IBD in France, exposed to anti-TNF, vedolizumab, and ustekinumab between 2014 and 2021. We compared pregnancy outcomes and complications in the offspring according to treatment exposure during pregnancy. We applied a propensity score matching for maternal, IBD, and pregnancy characteristics.
    Results: Three hundred ninety-eight pregnancies exposed to vedolizumab were compared with 1592 pregnancies exposed to anti-TNF; 464 pregnancies exposed to ustekinumab were compared with 1856 pregnancies exposed to anti-TNF. Overall, compared with anti-TNF, neither vedolizumab nor ustekinumab was associated with increased risks of abortion, caesarean section, stillbirth, preterm birth, serious infections, malignancies, or congenital abnormality in children. Women exposed to ustekinumab had an increased risk of small for gestational age births.
    Conclusions: Overall, the safety of vedolizumab and ustekinumab compared with anti-TNF use during pregnancy is reassuring. Further studies are needed to confirm these findings.
    Language English
    Publishing date 2024-01-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2023.12.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors.

    Jeay, Marine / Carbonnel, Franck / Robert, Caroline / Mussini, Charlotte / Bellanger, Christophe / Meyer, Antoine

    Clinics and research in hepatology and gastroenterology

    2024  Volume 48, Issue 4, Page(s) 102311

    Abstract: Background and aims: Immune checkpoint inhibitors (ICI) cause acute gastrointestinal (GI) immune-related adverse events (IrAEs). We aimed to report and describe chronic GI IrAEs.: Methods: We included consecutive patients addressed to a single center ...

    Abstract Background and aims: Immune checkpoint inhibitors (ICI) cause acute gastrointestinal (GI) immune-related adverse events (IrAEs). We aimed to report and describe chronic GI IrAEs.
    Methods: We included consecutive patients addressed to a single center between October 2010 and March 2022 for endoscopic and/or histological GI inflammation persisting at least six months after the last dose of ICI.
    Results: Among a total of 178 patients addressed for GI IrAE, 14 met the inclusion criteria (8 %). The median follow-up was 13 months after discontinuation of ICI. The most common symptom was watery diarrhea (54 %). Ten (77 %) patients had colonic involvement and three patients (21 %) had ileal involvement. Ten patients (77 %) had inflammatory lesions, two patients (15 %) had fistulas and one patient had (8 %) a stricture. All patients had lymphoplasmacytic infiltrate and basal plasmacytosis, and seven (54 %) had crypt distortions. Nine patients (69 %) received medical therapy, including five patients treated with vedolizumab, two patients (15 %) underwent intestinal resection. At the last follow-up, seven of the 13 patients were receiving maintenance therapy. Endoscopic lesions persisted one year after discontinuing ICI in 4/6 patients, and two years after discontinuation in 3/4 patients.
    Conclusions: Chronic GI IrAEs exist after ICI use.
    MeSH term(s) Humans ; Immune Checkpoint Inhibitors/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Retrospective Studies ; Colon ; Diarrhea/chemically induced
    Chemical Substances Immune Checkpoint Inhibitors ; Antineoplastic Agents, Immunological
    Language English
    Publishing date 2024-02-29
    Publishing country France
    Document type Journal Article
    ZDB-ID 2594333-9
    ISSN 2210-741X ; 2210-7401
    ISSN (online) 2210-741X
    ISSN 2210-7401
    DOI 10.1016/j.clinre.2024.102311
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: WallFlex

    Meyer, Antoine / Martin, Antoine / Bellanger, Christophe / Carbonnel, Franck / Boytchev, Isabelle

    Digestive diseases and sciences

    2023  Volume 68, Issue 9, Page(s) 3688–3693

    Abstract: Background: The WallFlex: Aims: We aimed to compare the efficacy and safety of WallFlex: Methods: We included all consecutive patients who were treated for malignant gastric outlet obstruction with WallFlex: Results: We included 129 patients: ... ...

    Abstract Background: The WallFlex
    Aims: We aimed to compare the efficacy and safety of WallFlex
    Methods: We included all consecutive patients who were treated for malignant gastric outlet obstruction with WallFlex
    Results: We included 129 patients: 74 received a WallFlex
    Conclusions: WallFlex
    MeSH term(s) Humans ; Treatment Outcome ; Retrospective Studies ; Stents/adverse effects ; Gastric Outlet Obstruction/etiology ; Gastric Outlet Obstruction/surgery ; Duodenum ; Palliative Care ; Duodenal Obstruction
    Language English
    Publishing date 2023-07-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-023-08036-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Editorial: ustekinumab during pregnancy - reassuring but still not enough.

    Amiot, Aurelien / Meyer, Antoine / Carbonnel, Franck

    Alimentary pharmacology & therapeutics

    2022  Volume 57, Issue 1, Page(s) 158–159

    MeSH term(s) Humans ; Pregnancy ; Female ; Ustekinumab/adverse effects
    Chemical Substances Ustekinumab (FU77B4U5Z0)
    Language English
    Publishing date 2022-12-28
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17260
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Progress in the Molecular and Histological Dissection of Crohn's Disease-associated Small Bowel Adenocarcinomas.

    Carbonnel, Franck / Svrcek, Magali

    Journal of Crohn's & colitis

    2020  Volume 14, Issue 3, Page(s) 283–284

    MeSH term(s) Adenocarcinoma ; Crohn Disease ; Dissection ; Humans ; Ileal Neoplasms ; Intestine, Small
    Language English
    Publishing date 2020-01-13
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 2390120-2
    ISSN 1876-4479 ; 1873-9946
    ISSN (online) 1876-4479
    ISSN 1873-9946
    DOI 10.1093/ecco-jcc/jjz166
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top